BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2004
View Archived Issues
Antibody targeting melanoma glycoprotein-proteoglycan complex shows anticancer efficacy in vivo
Read More
Preliminary phase II data on the antitumor efficacy of TG-4010 in NSCLC
Read More
Glycotope-specific antibody shows cytotoxic activity against gastrointestinal tumor in vivo
Read More
Anti-VEGFR antibody reduces lymphangiogenesis in vivo
Read More
A selective LXR agonist shows promise as an antiatherosclerotic agent
Read More
Novel NMDA GlyB-site antagonists discovered at Gruenenthal
Read More
Bayer claims new proteasome inhibitors for asthma and cancer
Read More
Novel tachykinin NK2/NK3 ligands discovered at Merck
Read More
New 5-HT1A ligands/5-HT reuptake inhibitors covered by Merck KGaA patent
Read More
Novartis scientists prepare and test new protein kinase C inhibitors
Read More
New CDK inhibitors in early development at Pfizer
Read More
New inhibitors of ERK2, GSK-3, PKA and CDK2 presented by Vertex
Read More
U.K. manufacturing for Fluvirin fails to comply with GMP regulations
Read More
rHuEPO active in wound healing
Read More
VEGF-toxin fusion protein inhibits tumor growth in vivo
Read More
Anti-PDGF receptor alpha antibody shows promising results in rodent glioblastoma model
Read More
Cytotoxic agent by Tapestry shows higher potency than paclitaxel in vitro
Read More
MDX-060 receives orphan drug status for Hodgkin's disease
Read More
MRL-123 decreases bone resorption and increases BMD in osteoporotic women
Read More
MC-45308 demonstrates simultaneous antiplatelet and anticoagulant effects
Read More
A product derived from bovine colostrum reduces the effects of HIV-associated diarrhea
Read More
Photrex chosen as new brand name for SnET2
Read More
Sustained reduction of testosterone levels achieved with Eligard 45 mg in prostate cancer patients
Read More
Good safety profile reported for HGS-ETR2 in advanced cancer patients
Read More
Santhera grants Genzyme license for discovery of therapies for muscular diseases
Read More
Six-month priority review for Pegasys sBLA
Read More
Expansion of Biolex and Centocor collaboration
Read More
Target enrollment reached in phase II study of methylnaltrexone for POI
Read More
New phase I study of aminocandin for systemic invasive fungal infections
Read More
MG-98 enters phase II study in metastatic renal cell cancer
Read More
